WallStreetZenWallStreetZen

NASDAQ: LGAC
Lazard Growth Acquisition Corp I Stock

Open Broker Account
$10.06+0.01 (+0.1%)
Updated Dec 8, 2022
LGAC Price
$10.06
Fair Value Price
$10.06
Market Cap
$722.70M
52 Week Low
$9.69
52 Week High
$10.07
P/E
59.15x
P/B
-27.04x
P/S
N/A
PEG
0.34x
Dividend Yield
N/A
Revenue
$0.00
Earnings
$14.01M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.03
Operating Cash Flow
-$2M
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

LGAC Overview

Lazard Growth Acquisition Corp. I is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the healthcare, tech, energy transition, and financial sectors. Lazard Growth Acquisition was incorporated in 2020 and is headquartered in New York, NY.

Zen Score

Industry Average (9)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LGAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LGAC ($10.06) is undervalued by 0.04% relative to our estimate of its Fair Value price of $10.06 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
LGAC ($10.06) is not significantly undervalued (0.04%) relative to our estimate of its Fair Value price of $10.06 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
LGAC ($10.06) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more LGAC due diligence checks available for Premium users.

Be the first to know about important LGAC news, forecast changes, insider trades & much more!

LGAC News

Valuation

LGAC fair value

Fair Value of LGAC stock based on Discounted Cash Flow (DCF)
Price
$10.06
Fair Value
$10.06
Overvalued by
0.01%
LGAC ($10.06) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LGAC ($10.06) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
LGAC ($10.06) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

LGAC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
59.15x
Industry
18.67x
Market
21.39x
LGAC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LGAC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

LGAC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-27.04x
Industry
-35.17x

LGAC price to earnings growth (PEG)

For valuing profitable companies with growth potential
LGAC is good value based... subscribe to Premium to read more.
PEG Value Valuation

LGAC's financial health

Profit margin

Revenue
$0.0
Net Income
$6.6M
Profit Margin
0%
LGAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$579.2M
Liabilities
$27.4M
Debt to equity
-1.03
LGAC's short-term liabilities ($6.28M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LGAC's long-term liabilities ($21.15M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LGAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LGAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$145.5k
Investing
$0.0
Financing
$0.0
LGAC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

LGAC vs Shell Company Stocks

TickerMarket Cap1d %P/EP/B
LGAC$722.70M+0.05%59.15x-27.04x
SLAM$722.34M-0.20%24.51x-31.00x
MSDA$720.91M0.00%14.54x-31.05x
SCOA$724.50M-0.20%25.20x-33.61x
FPAC$695.41M-0.20%14.66x-47.19x

Lazard Growth Acquisition I Stock FAQ

What is Lazard Growth Acquisition I's quote symbol?

NASDAQ: LGAC) Lazard Growth Acquisition I trades on the NASDAQ under the ticker symbol LGAC. Lazard Growth Acquisition I stock quotes can also be displayed as NASDAQ: LGAC.

If you're new to stock investing, here's how to buy Lazard Growth Acquisition I stock.

What is the 52 week high and low for Lazard Growth Acquisition I (NASDAQ: LGAC)?

(NASDAQ: LGAC) Lazard Growth Acquisition I's 52-week high was $10.07, and its 52-week low was $9.69. It is currently -0.15% from its 52-week high and 3.77% from its 52-week low.

How much is Lazard Growth Acquisition I stock worth today?

(NASDAQ: LGAC) Lazard Growth Acquisition I currently has 71,875,000 outstanding shares. With Lazard Growth Acquisition I stock trading at $10.06 per share, the total value of Lazard Growth Acquisition I stock (market capitalization) is $722.70M.

Lazard Growth Acquisition I stock was originally listed at a price of $10.42 in Feb 10, 2021. If you had invested in Lazard Growth Acquisition I stock at $10.42, your return over the last 1 years would have been -3.5%, for an annualized return of -3.5% (not including any dividends or dividend reinvestments).

How much is Lazard Growth Acquisition I's stock price per share?

(NASDAQ: LGAC) Lazard Growth Acquisition I stock price per share is $10.06 today (as of Dec 8, 2022).

What is Lazard Growth Acquisition I's Market Cap?

(NASDAQ: LGAC) Lazard Growth Acquisition I's market cap is $722.70M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Lazard Growth Acquisition I's market cap is calculated by multiplying LGAC's current stock price of $10.06 by LGAC's total outstanding shares of 71,875,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.